+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Molecular Imaging CRO Market - Global Forecast 2026-2032- Product Image
Molecular Imaging CRO Market - Global Forecast 2026-2032- Product Image
Sale

Molecular Imaging CRO Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6123998
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Molecular Imaging CRO Market is projected to reach USD 3.70 Billion in 2026. It is expected to continue growing at a CAGR of 17.17%, reaching USD 9.84 Billion by 2032.

Molecular Imaging CROs Enable More Reliable Translational Decisions

Molecular imaging contract research organizations (CROs) support drug developers with specialized imaging protocols, tracer handling, image acquisition, quantitative analysis, and biomarker interpretation. Their role is especially important when development programs require noninvasive assessment of target engagement, biodistribution, pharmacodynamics, disease progression, or treatment response. By combining clinical operations with imaging expertise, CROs can help sponsors standardize complex studies, improve data quality, and coordinate multidisciplinary stakeholders.

Decentralization, Biomarker Complexity, and Regulatory Rigor Are Reshaping Delivery

The operating landscape is shifting toward more distributed research networks, increasingly sophisticated imaging biomarkers, and greater scrutiny of reproducibility. Sponsors are seeking partners able to connect protocol design, site qualification, radiopharmaceutical logistics, scanner harmonization, central reading, and data management within a coherent workflow. At the same time, demand is rising for validated imaging endpoints that can support go/no-go decisions and complement conventional clinical and laboratory measures. These changes favor providers with strong quality systems, cross-site standardization, and experience managing operational complexity.

Artificial Intelligence Strengthens Image Analysis While Increasing Validation Requirements

Artificial intelligence is influencing molecular imaging CRO workflows through automated segmentation, lesion detection, tracer-uptake quantification, image reconstruction, quality control, and multimodal data integration. Properly governed tools may reduce manual workload and improve consistency, but their value depends on representative training data, transparent performance evaluation, version control, and qualified human oversight. CROs and sponsors must also address data privacy, algorithm drift, cybersecurity, explainability, and regulatory documentation before AI-generated outputs are used in consequential development decisions.

Regional Operating Conditions Create Distinct Molecular Imaging Priorities

North America benefits from mature clinical research infrastructure, specialized imaging centers, and established interactions among sponsors, CROs, and regulators. Europe combines advanced academic capabilities with cross-border coordination requirements, privacy obligations, and varied national health systems. Asia-Pacific is supported by expanding biomedical research capacity and growing interest in precision medicine, while operational practices and access to specialized tracers differ across markets. Latin America offers relevant patient populations and developing research networks, but logistics, site standardization, and regulatory coordination require careful planning. The Middle East is building specialized healthcare and research capabilities, whereas Africa presents important unmet-need and population-diversity opportunities alongside uneven access to imaging infrastructure and radiopharmaceutical supply.

Economic and Security Alliances Shape Collaboration and Compliance Needs

ASEAN markets require attention to differing regulatory processes, site capabilities, and cross-border logistics. BRICS countries collectively offer diverse research environments, patient populations, and scientific capabilities, but sponsors must manage variation in standards, data governance, and infrastructure. The European Union emphasizes harmonized scientific and privacy principles while retaining national implementation differences. G7 countries generally provide sophisticated research ecosystems and strong quality expectations. GCC members are investing in advanced healthcare infrastructure and precision-medicine capacity, while NATO countries may require additional consideration of security, data handling, and geopolitical continuity when studies span sensitive jurisdictions.

Country-Level Readiness Depends on Infrastructure, Regulation, and Specialist Capacity

Australia and Canada offer established research environments with strong clinical governance, while the United States combines extensive specialist capacity with complex multisite coordination. Germany, France, Italy, Spain, and the United Kingdom provide substantial European expertise, although national contracting, ethics, reimbursement, and data requirements must be addressed individually. Japan and South Korea have advanced imaging and biomedical capabilities, with local regulatory and operational practices shaping study execution. China and India provide significant scientific and clinical resources but require careful management of regulatory pathways, data localization, and site variability. Brazil and Mexico are important Latin American research markets where sponsor success depends on experienced local coordination, reliable logistics, and alignment with national requirements. Russia presents a distinct operating environment in which geopolitical, regulatory, data, and supply-chain considerations require heightened due diligence.

Leaders Should Build Standardized, Flexible, and Evidence-Ready Imaging Operations

Industry leaders should select CRO partners using evidence of protocol-specific imaging expertise, qualified sites, tracer and isotope logistics, validated central-reading processes, and measurable quality performance. Study plans should define acquisition parameters, harmonization procedures, endpoint adjudication, data standards, and escalation pathways before activation. Sponsors should also use risk-based site qualification, contingency planning for supply interruptions, and early regulatory engagement. For AI-enabled workflows, organizations should require documented validation, independent review, cybersecurity controls, and clear accountability for final interpretations. Long-term partnerships can improve consistency when they are governed by transparent performance metrics, data ownership terms, and continuous process improvement.

Research Methodology Combines Structured Market Framing With Evidence-Based Operational Analysis

This executive summary uses the defined molecular imaging CRO market scope and evaluates the field through established dimensions of service delivery, translational research, imaging technology, regulatory requirements, regional conditions, and stakeholder needs. The assessment emphasizes verifiable operational themes rather than numerical market estimation. Regional, group, and country perspectives are synthesized from differences in research infrastructure, clinical-trial governance, radiopharmaceutical access, data policies, imaging specialization, and cross-border coordination. Conclusions are framed as strategic implications and should be validated against current regulations, site-level capabilities, and program-specific evidence before implementation.

Molecular Imaging CRO Value Will Depend on Reproducibility, Integration, and Responsible Innovation

Molecular imaging CROs are becoming strategic partners for development programs that require sensitive, noninvasive, and quantitatively reliable evidence. Competitive differentiation will increasingly rest on the ability to integrate imaging science, clinical operations, radiopharmaceutical logistics, data engineering, and quality assurance across jurisdictions. Artificial intelligence can enhance these capabilities, but only when supported by rigorous validation and governance. Sponsors that prioritize standardized execution, regional fit, resilient supply chains, and transparent evidence generation will be better positioned to translate imaging data into confident development decisions.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Molecular Imaging CRO Market, by Imaging Modality
7.1. Introduction
7.2. MRI
7.3. Optical Imaging
7.3.1. Bioluminescence Imaging
7.3.2. Fluorescence Imaging
7.4. PET
7.4.1. Clinical PET
7.4.2. Preclinical PET
7.5. SPECT
7.5.1. Clinical SPECT
7.5.2. Preclinical SPECT
8. Molecular Imaging CRO Market, by Application
8.1. Introduction
8.2. Cardiology
8.2.1. Heart Failure Imaging
8.2.2. Myocardial Perfusion Imaging
8.3. Inflammation
8.3.1. Autoimmune Imaging
8.3.2. Infection Imaging
8.4. Neurology
8.4.1. Alzheimer's Imaging
8.4.2. Parkinson's Imaging
8.5. Oncology
8.5.1. Hematological Tumor Imaging
8.5.2. Solid Tumor Imaging
9. Molecular Imaging CRO Market, by Service Type
9.1. Introduction
9.2. Data Analysis
9.3. Imaging Services
9.4. Radiotracer Development
10. Molecular Imaging CRO Market, by End User
10.1. Introduction
10.2. Academic Research Institutes
10.3. Contract Research Organizations
10.4. Hospitals & Diagnostic Centers
10.5. Pharmaceutical Biotech
11. Molecular Imaging CRO Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Molecular Imaging CRO Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Molecular Imaging CRO Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. ABX-CRO Advanced Pharmaceutical Services, LLC
15.2. Bioclinica, Inc.
15.3. Biomedical Systems Corporation
15.4. Biospective, Inc.
15.5. Biotrial, SA
15.6. Blue Earth Diagnostics Ltd.
15.7. Charles River Laboratories International, Inc.
15.8. Crown Bioscience, Inc.
15.9. Gubra A/S
15.10. ICON plc
15.11. Image Analysis Group, LLC
15.12. Imaging Endpoints, Inc.
15.13. IQVIA Holdings Inc.
15.14. Labcorp Drug Development, Inc.
15.15. Medpace Holdings, Inc.
15.16. Micron, Inc.
15.17. Oncodesign SA
15.18. Parexel International Corporation
15.19. Serac Life Sciences, Inc.
15.20. Tracer CRO, LLC
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Molecular Imaging CRO Market, Years Considered for the Study
FIGURE 2. Global Molecular Imaging CRO Market, Research Design
FIGURE 3. Global Molecular Imaging CRO Market, Research Framework
FIGURE 4. Global Molecular Imaging CRO Market, Data Triangulation
FIGURE 5. Global Molecular Imaging CRO Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Molecular Imaging CRO Market Size, by Imaging Modality, 2025 vs 2032 (%)
FIGURE 7. Global Molecular Imaging CRO Market Size, by Imaging Modality, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Molecular Imaging CRO Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global Molecular Imaging CRO Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Molecular Imaging CRO Market Size, by Service Type, 2025 vs 2032 (%)
FIGURE 11. Global Molecular Imaging CRO Market Size, by Service Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Molecular Imaging CRO Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Molecular Imaging CRO Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Molecular Imaging CRO Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Molecular Imaging CRO Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Molecular Imaging CRO Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Molecular Imaging CRO Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Molecular Imaging CRO Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Molecular Imaging CRO Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Molecular Imaging CRO Market Segmentation & Coverage
TABLE 2. Global Molecular Imaging CRO Market Size, 2017-2032 (USD Million)
TABLE 3. Global Molecular Imaging CRO Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 4. Global MRI Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global MRI Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global MRI Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Optical Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Optical Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Optical Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Bioluminescence Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Bioluminescence Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Bioluminescence Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Fluorescence Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Fluorescence Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Fluorescence Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global PET Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global PET Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global PET Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Clinical PET Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Clinical PET Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Clinical PET Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Preclinical PET Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Preclinical PET Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Preclinical PET Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global SPECT Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global SPECT Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global SPECT Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Clinical SPECT Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Clinical SPECT Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Clinical SPECT Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Preclinical SPECT Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Preclinical SPECT Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Preclinical SPECT Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Molecular Imaging CRO Market Size, by Application, 2017-2032 (USD Million)
TABLE 35. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Heart Failure Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Heart Failure Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Heart Failure Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Myocardial Perfusion Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Myocardial Perfusion Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Myocardial Perfusion Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Inflammation Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Inflammation Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Inflammation Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Autoimmune Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Autoimmune Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Autoimmune Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Infection Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Infection Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Infection Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Alzheimer's Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Alzheimer's Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Alzheimer's Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Parkinson's Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Parkinson's Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Parkinson's Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Hematological Tumor Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Hematological Tumor Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Hematological Tumor Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Solid Tumor Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Solid Tumor Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Solid Tumor Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Molecular Imaging CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 72. Global Data Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Data Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Data Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Imaging Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Imaging Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Imaging Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Radiotracer Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Radiotracer Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Radiotracer Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Molecular Imaging CRO Market Size, by End User, 2017-2032 (USD Million)
TABLE 82. Global Academic Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Academic Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Academic Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Hospitals & Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Hospitals & Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Hospitals & Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Pharmaceutical Biotech Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Pharmaceutical Biotech Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Pharmaceutical Biotech Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Molecular Imaging CRO Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Molecular Imaging CRO Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Molecular Imaging CRO Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Molecular Imaging CRO Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Molecular Imaging CRO Market Size, by PET, 2017-2032 (USD Million)
TABLE 99. Asia-Pacific Molecular Imaging CRO Market Size, by SPECT, 2017-2032 (USD Million)
TABLE 100. Asia-Pacific Molecular Imaging CRO Market Size, by Application, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Molecular Imaging CRO Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Molecular Imaging CRO Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Molecular Imaging CRO Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Molecular Imaging CRO Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Molecular Imaging CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Molecular Imaging CRO Market Size, by End User, 2017-2032 (USD Million)
TABLE 107. North America Molecular Imaging CRO Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. North America Molecular Imaging CRO Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 109. North America Molecular Imaging CRO Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 110. North America Molecular Imaging CRO Market Size, by PET, 2017-2032 (USD Million)
TABLE 111. North America Molecular Imaging CRO Market Size, by SPECT, 2017-2032 (USD Million)
TABLE 112. North America Molecular Imaging CRO Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. North America Molecular Imaging CRO Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 114. North America Molecular Imaging CRO Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 115. North America Molecular Imaging CRO Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 116. North America Molecular Imaging CRO Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 117. North America Molecular Imaging CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 118. North America Molecular Imaging CRO Market Size, by End User, 2017-2032 (USD Million)
TABLE 119. Latin America Molecular Imaging CRO Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Latin America Molecular Imaging CRO Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 121. Latin America Molecular Imaging CRO Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 122. Latin America Molecular Imaging CRO Market Size, by PET, 2017-2032 (USD Million)
TABLE 123. Latin America Molecular Imaging CRO Market Size, by SPECT, 2017-2032 (USD Million)
TABLE 124. Latin America Molecular Imaging CRO Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. Latin America Molecular Imaging CRO Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 126. Latin America Molecular Imaging CRO Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 127. Latin America Molecular Imaging CRO Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 128. Latin America Molecular Imaging CRO Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 129. Latin America Molecular Imaging CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 130. Latin America Molecular Imaging CRO Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. Europe Molecular Imaging CRO Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Europe Molecular Imaging CRO Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 133. Europe Molecular Imaging CRO Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 134. Europe Molecular Imaging CRO Market Size, by PET, 2017-2032 (USD Million)
TABLE 135. Europe Molecular Imaging CRO Market Size, by SPECT, 2017-2032 (USD Million)
TABLE 136. Europe Molecular Imaging CRO Market Size, by Application, 2017-2032 (USD Million)
TABLE 137. Europe Molecular Imaging CRO Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 138. Europe Molecular Imaging CRO Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 139. Europe Molecular Imaging CRO Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 140. Europe Molecular Imaging CRO Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 141. Europe Molecular Imaging CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 142. Europe Molecular Imaging CRO Market Size, by End User, 2017-2032 (USD Million)
TABLE 143. Middle East Molecular Imaging CRO Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Middle East Molecular Imaging CRO Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 145. Middle East Molecular Imaging CRO Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 146. Middle East Molecular Imaging CRO Market Size, by PET, 2017-2032 (USD Million)
TABLE 147. Middle East Molecular Imaging CRO Market Size, by SPECT, 2017-2032 (USD Million)
TABLE 148. Middle East Molecular Imaging CRO Market Size, by Application, 2017-2032 (USD Million)
TABLE 149. Middle East Molecular Imaging CRO Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 150. Middle East Molecular Imaging CRO Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 151. Middle East Molecular Imaging CRO Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 152. Middle East Molecular Imaging CRO Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 153. Middle East Molecular Imaging CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 154. Middle East Molecular Imaging CRO Market Size, by End User, 2017-2032 (USD Million)
TABLE 155. Africa Molecular Imaging CRO Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Africa Molecular Imaging CRO Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 157. Africa Molecular Imaging CRO Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 158. Africa Molecular Imaging CRO Market Size, by PET, 2017-2032 (USD Million)
TABLE 159. Africa Molecular Imaging CRO Market Size, by SPECT, 2017-2032 (USD Million)
TABLE 160. Africa Molecular Imaging CRO Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. Africa Molecular Imaging CRO Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 162. Africa Molecular Imaging CRO Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 163. Africa Molecular Imaging CRO Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 164. Africa Molecular Imaging CRO Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 165. Africa Molecular Imaging CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 166. Africa Molecular Imaging CRO Market Size, by End User, 2017-2032 (USD Million)
TABLE 167. Global Molecular Imaging CRO Market Size, by Group, 2017-2032 (USD Million)
TABLE 168. ASEAN Molecular Imaging CRO Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. ASEAN Molecular Imaging CRO Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 170. ASEAN Molecular Imaging CRO Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 171. ASEAN Molecular Imaging CRO Market Size, by PET, 2017-2032 (USD Million)
TABLE 172. ASEAN Molecular Imaging CRO Market Size, by SPECT, 2017-2032 (USD Million)
TABLE 173. ASEAN Molecular Imaging CRO Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. ASEAN Molecular Imaging CRO Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 175. ASEAN Molecular Imaging CRO Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 176. ASEAN Molecular Imaging CRO Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 177. ASEAN Molecular Imaging CRO Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 178. ASEAN Molecular Imaging CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 179. ASEAN Molecular Imaging CRO Market Size, by End User, 2017-2032 (USD Million)
TABLE 180. GCC Molecular Imaging CRO Market Size, by Group, 2017-2032 (USD Million)
TABLE 181. GCC Molecular Imaging CRO Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 182. GCC Molecular Imaging CRO Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 183. GCC Molecular Imaging CRO Market Size, by PET, 2017-2032 (USD Million)
TABLE 184. GCC Molecular Imaging CRO Market Size, by SPECT, 2017-2032 (USD Million)
TABLE 185. GCC Molecular Imaging CRO Market Size, by Application, 2017-2032 (USD Million)
TABLE 186. GCC Molecular Imaging CRO Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 187. GCC Molecular Imaging CRO Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 188. GCC Molecular Imaging CRO Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 189. GCC Molecular Imaging CRO Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 190. GCC Molecular Imaging CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 191. GCC Molecular Imaging CRO Market Size, by End User, 2017-2032 (USD Million)
TABLE 192. European Union Molecular Imaging CRO Market Size, by Group, 2017-2032 (USD Million)
TABLE 193. European Union Molecular Imaging CRO Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 194. European Union Molecular Imaging CRO Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 195. European Union Molecular Imaging CRO Market Size, by PET, 2017-2032 (USD Million)
TABLE 196. European Union Molecular Imaging CRO Market Size, by SPECT, 2017-2032 (USD Million)
TABLE 197. European Union Molecular Imaging CRO Market Size, by Application, 2017-2032 (USD Million)
TABLE 198. European Union Molecular Imaging CRO Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 199. European Union Molecular Imaging CRO Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 200. European Union Molecular Imaging CRO Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 201. European Union Molecular Imaging CRO Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 202. European Union Molecular Imaging CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 203. European Union Molecular Imaging CRO Market Size, by End User, 2017-2032 (USD Million)
TABLE 204. BRICS Molecular Imaging CRO Market Size, by Group, 2017-2032 (USD Million)
TABLE 205. BRICS Molecular Imaging CRO Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 206. BRICS Molecular Imaging CRO Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 207. BRICS Molecular Imaging CRO Market Size, by PET, 2017-2032 (USD Million)
TABLE 208. BRICS Molecular Imaging CRO Market Size, by SPECT, 2017-2032 (USD Million)
TABLE 209. BRICS Molecular Imaging CRO Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. BRICS Molecular Imaging CRO Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 211. BRICS Molecular Imaging CRO Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 212. BRICS Molecular Imaging CRO Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 213. BRICS Molecular Imaging CRO Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 214. BRICS Molecular Imaging CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 215. BRICS Molecular Imaging CRO Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. G7 Molecular Imaging CRO Market Size, by Group, 2017-2032 (USD Million)
TABLE 217. G7 Molecular Imaging CRO Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 218. G7 Molecular Imaging CRO Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 219. G7 Molecular Imaging CRO Market Size, by PET, 2017-2032 (USD Million)
TABLE 220. G7 Molecular Imaging CRO Market Size, by SPECT, 2017-2032 (USD Million)
TABLE 221. G7 Molecular Imaging CRO Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. G7 Molecular Imaging CRO Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 223. G7 Molecular Imaging CRO Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 224. G7 Molecular Imaging CRO Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 225. G7 Molecular Imaging CRO Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 226. G7 Molecular Imaging CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 227. G7 Molecular Imaging CRO Market Size, by End User, 2017-2032 (USD Million)
TABLE 228. NATO Molecular Imaging CRO Market Size, by Group, 2017-2032 (USD Million)
TABLE 229. NATO Molecular Imaging CRO Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 230. NATO Molecular Imaging CRO Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 231. NATO Molecular Imaging CRO Market Size, by PET, 2017-2032 (USD Million)
TABLE 232. NATO Molecular Imaging CRO Market Size, by SPECT, 2017-2032 (USD Million)
TABLE 233. NATO Molecular Imaging CRO Market Size, by Application, 2017-2032 (USD Million)
TABLE 234. NATO Molecular Imaging CRO Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 235. NATO Molecular Imaging CRO Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 236. NATO Molecular Imaging CRO Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 237. NATO Molecular Imaging CRO Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 238. NATO Molecular Imaging CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 239. NATO Molecular Imaging CRO Market Size, by End User, 2017-2032 (USD Million)
TABLE 240. Global Molecular Imaging CRO Market Size, by Country, 2017-2032 (USD Million)
TABLE 241. United States Molecular Imaging CRO Market Size, 2017-2032 (USD Million)
TABLE 242. United States Molecular Imaging CRO Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 243. United States Molecular Imaging CRO Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 244. United States Molecular Imaging CRO Market Size, by PET, 2017-2032 (USD Million)
TABLE 245. United States Molecular Imaging CRO Market Size, by SPECT, 2017-2032 (USD Million)
TABLE 246. United States Molecular Imaging CRO Market Size, by Application, 2017-2032 (USD Million)
TABLE 247. United States Molecular Imaging CRO Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 248. United States Molecular Imaging CRO Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 249. United States Molecular Imaging CRO Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 250. United States Molecular Imaging CRO Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 251. United States Molecular Imaging CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 252. United States Molecular Imaging CRO Market Size, by End User, 2017-2032 (USD Million)
TABLE 253. Canada Molecular Imaging CRO Market Size, 2017-2032 (USD Million)
TABLE 254. Canada Molecular Imaging CRO Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 255. Canada Molecular Imaging CRO Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 256. Canada Molecular Imaging CRO Market Size, by PET, 2017-2032 (USD Million)
TABLE 257. Canada Molecular Imaging CRO Market Size, by SPECT, 2017-2032 (USD Million)
TABLE 258. Canada Molecular Imaging CRO Market Size, by Application, 2017-2032 (USD Million)
TABLE 259. Canada Molecular Imaging CRO Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 260. Canada Molecular Imaging CRO Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 261. Canada Molecular Imaging CRO Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 262. Canada Molecular Imaging CRO Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 263. Canada Molecular Imaging CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 264. Canada Molecular Imaging CRO Market Size, by End User, 2017-2032 (USD Million)
TABLE 265. Mexico Molecular Imaging CRO Market Size, 2017-2032 (USD Million)
TABLE 266. Mexico Molecular Imaging CRO Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 267. Mexico Molecular Imaging CRO Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 268. Mexico Molecular Imaging CRO Market Size, by PET, 2017-2032 (USD Million)
TABLE 269. Mexico Molecular Imaging CRO Market Size, by SPECT, 2017-2032 (USD Million)
TABLE 270. Mexico Molecular Imaging CRO Market Size, by Application, 2017-2032 (USD Million)
TABLE 271. Mexico Molecular Imaging CRO Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 272. Mexico Molecular Imaging CRO Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 273. Mexico Molecular Imaging CRO Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 274. Mexico Molecular Imaging CRO Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 275. Mexico Molecular Imaging CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 276. Mexico Molecular Imaging CRO Market Size, by End User, 2017-2032 (USD Million)
TABLE 277. Brazil Molecular Imaging CRO Market Size, 2017-2032 (USD Million)
TABLE 278. Brazil Molecular Imaging CRO Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 279. Brazil Molecular Imaging CRO Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 280. Brazil Molecular Imaging CRO Market Size, by PET, 2017-2032 (USD Million)
TABLE 281. Brazil Molecular Imaging CRO Market Size, by SPECT, 2017-2032 (USD Million)
TABLE 282. Brazil Molecular Imaging CRO Market Size, by Application, 2017-2032 (USD Million)
TABLE 283. Brazil Molecular Imaging CRO Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 284. Brazil Molecular Imaging CRO Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 285. Brazil Molecular Imaging CRO Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 286. Brazil Molecular Imaging CRO Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 287. Brazil Molecular Imaging CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 288. Brazil Molecular Imaging CRO Market Size, by End User, 2017-2032 (USD Million)
TABLE 289. United Kingdom Molecular Imaging CRO Market Size, 2017-2032 (USD Million)
TABLE 290. United Kingdom Molecular Imaging CRO Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 291. United Kingdom Molecular Imaging CRO Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 292. United Kingdom Molecular Imaging CRO Market Size, by PET, 2017-2032 (USD Million)
TABLE 293. United Kingdom Molecular Imaging CRO Market Size, by SPECT, 2017-2032 (USD Million)
TABLE 294. United Kingdom Molecular Imaging CRO Market Size, by Application, 2017-2032 (USD Million)
TABLE 295. United Kingdom Molecular Imaging CRO Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 296. United Kingdom Molecular Imaging CRO Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 297. United Kingdom Molecular Imaging CRO Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 298. United Kingdom Molecular Imaging CRO Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 299. United Kingdom Molecular Imaging CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 300. United Kingdom Molecular Imaging CRO Market Size, by End User, 2017-2032 (USD Million)
TABLE 301. Germany Molecular Imaging CRO Market Size, 2017-2032 (USD Million)
TABLE 302. Germany Molecular Imaging CRO Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 303. Germany Molecular Imaging CRO Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 304. Germany Molecular Imaging CRO Market Size, by PET, 2017-2032 (USD Million)
TABLE 305. Germany Molecular Imaging CRO Market Size, by SPECT, 2017-2032 (USD Million)
TABLE 306. Germany Molecular Imaging CRO Market Size, by Application, 2017-2032 (USD Million)
TABLE 307. Germany Molecular Imaging CRO Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 308. Germany Molecular Imaging CRO Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 309. Germany Molecular Imaging CRO Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 310. Germany Molecular Imaging CRO Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 311. Germany Molecular Imaging CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 312. Germany Molecular Imaging CRO Market Size, by End User, 2017-2032 (USD Million)
TABLE 313. France Molecular Imaging CRO Market Size, 2017-2032 (USD Million)
TABLE 314. France Molecular Imaging CRO Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 315. France Molecular Imaging CRO Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 316. France Molecular Imaging CRO Market Size, by PET, 2017-2032 (USD Million)
TABLE 317. France Molecular Imaging CRO Market Size, by SPECT, 2017-2032 (USD Million)
TABLE 318. France Molecular Imaging CRO Market Size, by Application, 2017-2032 (USD Million)
TABLE 319. France Molecular Imaging CRO Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 320. France Molecular Imaging CRO Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 321. France Molecular Imaging CRO Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 322. France Molecular Imaging CRO Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 323. France Molecular Imaging CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 324. France Molecular Imaging CRO Market Size, by End User, 2017-2032 (USD Million)
TABLE 325. Russia Molecular Imaging CRO Market Size, 2017-2032 (USD Million)
TABLE 326. Russia Molecular Imaging CRO Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 327. Russia Molecular Imaging CRO Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 328. Russia Molecular Imaging CRO Market Size, by PET, 2017-2032 (USD Million)
TABLE 329. Russia Molecular Imaging CRO Market Size, by SPECT, 2017-2032 (USD Million)
TABLE 330. Russia Molecular Imaging CRO Market Size, by Application, 2017-2032 (USD Million)
TABLE 331. Russia Molecular Imaging CRO Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 332. Russia Molecular Imaging CRO Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 333. Russia Molecular Imaging CRO Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 334. Russia Molecular Imaging CRO Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 335. Russia Molecular Imaging CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 336. Russia Molecular Imaging CRO Market Size, by End User, 2017-2032 (USD Million)
TABLE 337. Italy Molecular Imaging CRO Market Size, 2017-2032 (USD Million)
TABLE 338. Italy Molecular Imaging CRO Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 339. Italy Molecular Imaging CRO Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 340. Italy Molecular Imaging CRO Market Size, by PET, 2017-2032 (USD Million)
TABLE 341. Italy Molecular Imaging CRO Market Size, by SPECT, 2017-2032 (USD Million)
TABLE 342. Italy Molecular Imaging CRO Market Size, by Application, 2017-2032 (USD Million)
TABLE 343. Italy Molecular Imaging CRO Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 344. Italy Molecular Imaging CRO Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 345. Italy Molecular Imaging CRO Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 346. Italy Molecular Imaging CRO Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 347. Italy Molecular Imaging CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 348. Italy Molecular Imaging CRO Market Size, by End User, 2017-2032 (USD Million)
TABLE 349. Spain Molecular Imaging CRO Market Size, 2017-2032 (USD Million)
TABLE 350. Spain Molecular Imaging CRO Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 351. Spain Molecular Imaging CRO Market Size, by Optical Imaging, 2017-2032 (USD Million)
TABLE 352. Spain Molecular Imaging CRO Market Size, by PET, 2017-2032 (USD Million)
TABLE 353. Spain Molecular Imaging CRO Market Size, by SPECT, 2017-2032 (USD Million)
TABLE 354. Spain Molecular Imaging CRO Market Size, by Application, 2017-2032 (USD Million)
TABLE 355. Spain Molecular Imaging CRO Market Size, by Cardiology, 2017-2032 (USD Million)
TABLE 356. Spain Molecular Imaging CRO Market Size, by Inflammation, 2017-2032 (USD Million)
TABLE 357. Spain Molecular Imaging CRO Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 358. Spain Molecular Imaging CRO Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 359. Spain Molecular Imaging CRO Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 360. Spain Molecular Imaging CRO Market Size, by End User, 2017-2032 (USD Million)
TABLE 361. China Molecular Imaging CRO Market Size, 2017-2032 (USD Million)
TABLE 362. China Molecular Imaging CRO Market Size, by Imaging Modality, 2017-2032 (USD Million)
TABLE 363. China Molecular Imaging CRO Market Size, by Optical Imaging, 2017-2032 (USD Million)
TAB

Companies Mentioned

  • ABX-CRO Advanced Pharmaceutical Services, LLC
  • Bioclinica, Inc.
  • Biomedical Systems Corporation
  • Biospective, Inc.
  • Biotrial, SA
  • Blue Earth Diagnostics Ltd.
  • Charles River Laboratories International, Inc.
  • Crown Bioscience, Inc.
  • Gubra A/S
  • ICON plc
  • Image Analysis Group, LLC
  • Imaging Endpoints, Inc.
  • IQVIA Holdings Inc.
  • Labcorp Drug Development, Inc.
  • Medpace Holdings, Inc.
  • Micron, Inc.
  • Oncodesign SA
  • Parexel International Corporation
  • Serac Life Sciences, Inc.
  • Tracer CRO, LLC

Related Topics

Related Reports

Imaging CRO Market - Global Forecast 2026-2032 - Product Image

Imaging CRO Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Oncology Based In-Vivo CRO Market Report by Indication, Model, Application, and Region 2026-2034 - Product Image

Oncology Based In-Vivo CRO Market Report by Indication, Model, Application, and Region 2026-2034

  • Report
  • 136 Pages
  • Global
From
In Vivo CRO Market - Global Forecast 2026-2032 - Product Image

In Vivo CRO Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
In Vivo Contract Research Organization (CRO) - Global Strategic Business Report - Product Image

In Vivo Contract Research Organization (CRO) - Global Strategic Business Report

  • Report
  • 220 Pages
  • Global
From
Imaging Cro Market Outlook 2026-2034: Market Share and Growth Analysis - Product Image

Imaging Cro Market Outlook 2026-2034: Market Share and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.